MicroRNA expression profile and identification of novel microRNA biomarkers for metabolic syndrome

References

• Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5–6):231–237.
   PubMed Web of Science ®Google Scholar
• Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev. 2008;29(7):777–822.
   PubMed Web of Science ®Google Scholar
• Elabbassi WN, Haddad HA. The epidemic of the metabolic syndrome. Saudi Med J. 2005;26(3):373–375.
   PubMed Web of Science ®Google Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207.
   PubMed Web of Science ®Google Scholar
• O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12.
   PubMed Web of Science ®Google Scholar
• Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004;68(11):975–981. Available from: http://www.eurjmedres.com/%5Cnhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=20160241769
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Noshad S, Khalilzadeh O, et al. Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects. Arch Med Res. 2011;42(3):244–251.
   PubMed Web of Science ®Google Scholar
• Seok H, Ham J, Jang ES, et al. MicroRNA target recognition: insights from transcriptome-wide non-canonical interactions. Mol Cells. 2016;39(5):375–381.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun X, Icli B, et al. Emerging roles for microRNAs in diabetic microvascular disease: novel targets for therapy. Endocr Rev. 2017;38(2):145–168.
   PubMed Web of Science ®Google Scholar
• Halushka PV, Goodwin AJ, Halushka MK. Opportunities for microRNAs in the crowded field of cardiovascular biomarkers. Annu Rev Pathol Mech Dis. 2019;14(1):211–238.
   PubMed Web of Science ®Google Scholar
• Goh JN, Loo SY, Datta A, et al. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer. Biol Rev. 2016;91(2):409–428.
   PubMed Web of Science ®Google Scholar
• Willeit P, Skroblin P, Moschen AR, et al. Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes. Diabetes. 2017;66(2):347–357.
   PubMed Web of Science ®Google Scholar
• Guo X, Yang Q, Zhang W, et al. Associations of blood levels of trace elements and heavy metals with metabolic syndrome in Chinese male adults with microRNA as mediators involved. Environ Pollut. 2019;248:66–73.
   PubMed Web of Science ®Google Scholar
• Raitoharju E, Seppälä I, Oksala N, et al. Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome. The cardiovascular risk in Young Finns Study. Mol Cell Endocrinol. 2014;391(1–2):41–49.
   PubMed Web of Science ®Google Scholar
• Kechin A, Boyarskikh U, Kel A, et al. Primers from reads of targeted next generation sequencing. J Comput Biol. 2017;24(11). DOI:10.1089/cmb.2017.0096
   PubMed Web of Science ®Google Scholar
• Friedländer MR, MacKowiak SD, Li N, et al. MiRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2012;40(1):37–52.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26(1):139–140.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. Omi A J Integr Biol. 2012;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Ter Horst R, Van Den Munckhof ICL, Schraa K, et al. Sex-specific regulation of inflammation and metabolic syndrome in obesity. Arterioscler Thromb Vasc Biol. 2020;(July):1787–1800. DOI:10.1161/ATVBAHA.120.314508
   PubMedGoogle Scholar
• Ruderman NB, Carling D, Prentki M, et al. AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest. 2013;123(7):2764–2772.
   PubMed Web of Science ®Google Scholar
• Ewa S, Podolska M, Strycharz J, et al. Hyperglycemia changes expression of key adipogenesis markers (C/EBPα and PPARγ) and morphology of differentiating human visceral adipocytes. Nutrients. 2019;11:1835.
   PubMed Web of Science ®Google Scholar
• Teichenne J, Morró M, Casellas A, et al. Identification of miRNAs involved in reprogramming acinar cells into insulin producing cells. PLoS One. 2015;10(12):1–20.
   Web of Science ®Google Scholar
• Ventriglia G, Mancarella F, Sebastiani G, et al. miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes. Diabetologia. 2020;63(1):124–136.
   PubMed Web of Science ®Google Scholar
• Jialal I, Adams-Huet B, Pahwa R. Selective increase in monocyte p38 mitogen-activated protein kinase activity in metabolic syndrome. Diab Vasc Dis Res. 2016;13(1):93–96.
   PubMed Web of Science ®Google Scholar
• Li H, Wang YP, Zhang LN, et al. Perivascular adipose tissue-derived leptin promotes vascular smooth muscle cell phenotypic switching via p38 mitogen-activated protein kinase in metabolic syndrome rats. Exp Biol Med. 2014;239(8):954–965.
   PubMed Web of Science ®Google Scholar
• Asrih M, MacH F, Nencioni A, et al. Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome. Mediators Inflamm. 2013;2013. DOI:10.1155/2013/367245
   Web of Science ®Google Scholar
• Tang Z, Xia N, Yuan X, et al. PRDX1 is involved in palmitate induced insulin resistance via regulating the activity of p38MAPK in HepG2 cells. Biochem Biophys Res Commun. 2015;465(4):670–677.
   PubMed Web of Science ®Google Scholar
• Bashan N, Dorfman K, Tarnovscki T, et al. Mitogen-activated protein kinases, inhibitory-κB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology. 2007;148(6):2955–2962.
   PubMed Web of Science ®Google Scholar
• Li L, Yang G, Liao G, et al. Glucocorticoid treatment facilitates development of a metabolic syndrome in ovariectomized Macaca Mulatta fed a high fat diet. Steroids. 2017;128:105–113.
   PubMed Web of Science ®Google Scholar
• Baudrand R, Campino C, Carvajal CA, et al. High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome. Clin Endocrinol (Oxf). 2014;80(5):677–684.
   PubMed Web of Science ®Google Scholar
• Kita S, Maeda N, Shimomura I. Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome. J Clin Invest. 2019;129(10):4041–4049.
   PubMed Web of Science ®Google Scholar
• Ying W, Riopel M, Bandyopadhyay G, et al. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell. 2017;171(2):372–384.e12.
   PubMed Web of Science ®Google Scholar
• Pan Y, Hui X, Chong Hoo RL, et al. Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation. J Clin Invest. 2019;129(2):834–849.
   PubMed Web of Science ®Google Scholar
• Naik JS, Xiang L, Hester RL. Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats. Am J Physiol - Regul Integr Comp Physiol. 2006;290(1). DOI:10.1152/ajpregu.00245.2005
   Web of Science ®Google Scholar
• Leguina-Ruzzi A, Pereira J, Pereira-Flores K, et al. Increased RhoA/Rho-kinase activity and markers of endothelial dysfunction in young adult subjects with metabolic syndrome. Metab Syndr Relat Disord. 2015;13(9):373–380.
   PubMed Web of Science ®Google Scholar
• Huang X, Charbeneau RA, Fu Y, et al. Resistance to diet-induced obesity and improved insulin sensitivity in mice with a regulator of G protein signaling-insensitive G184S Gnai2 allele. Diabetes. 2008;57(1):77–85.
   PubMed Web of Science ®Google Scholar
• Lee YS, Morinaga H, Kim JJ, et al. The fractalkine/CX3CR1 system regulates β cell function and insulin secretion. Cell. 2013;153(2):413–425.
   PubMed Web of Science ®Google Scholar
• Martínez-Hervás S, Vinué Á, Núñez L, et al. Insulin resistance aggravates atherosclerosis by reducing vascular smoothmuscle cell survival and increasing CX3CL1/CX3CR1 axis. Cardiovasc Res. 2014;103(2):324–336.
   PubMed Web of Science ®Google Scholar
• Xueyao Y, Saifei Z, Dan Y, et al. Circulating fractalkine levels predict the development of the metabolic syndrome. Int J Endocrinol. 2014;2014:1–9.
   PubMed Web of Science ®Google Scholar